Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-1,009,3684 Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
Certain imidazopyrazines of Formula I and pharmaceutical compositions thereof are provided herein: ##STR00001## Methods of treating patients suffering from...
US-1,009,3683 Factor XIa inhibitors
The present invention provides a compound of Formula (I) ##STR00001## and pharmaceutical compositions comprising one or more compounds of Formula (I), and...
US-1,009,3682 Method for synthesizing tetrahydroisoquinoline oxazolidine
The invention relates to a method for synthesizing tetrahydroisoquinoline oxazolidine. The method is carried out at a room temperature between 20.degree. C. and...
US-1,009,3681 Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
The present invention provides oxazine compounds, method of using and method of making oxazine compounds and its pharmaceutical use.
US-1,009,3680 Asymmetric benzotrichalcogenophene compound, synthesis method thereof and polymer
A synthesis method of benzotrichalcogenophene (BTC) includes using a tetrakis(triphenylphosphine)palladium (Pd(PPh.sub.3).sub.4) catalyst and a...
US-1,009,3679 Amino sulfonyl-based compounds, the preparation method therefor and use thereof
Disclosed are aminosulfonyl-based compounds represented by the general formula I or tautomers, enantiomers, racemates or pharmaceutically acceptable salts...
US-1,009,3678 Azaspiro derivatives as TRPM8 antagonists
The present invention relates to azaspiro derivatives of the formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their...
US-1,009,3677 Method for preparing spiro quaternary ammonium salt
The present invention relates to a method for preparing a spiro quaternary ammonium salt comprising reacting a cyclic secondary amine with a dihaloalkane in the...
US-1,009,3676 Compounds useful as inhibitors of ATR kinase
The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention relates to pharmaceutically acceptable compositions...
US-1,009,3675 6,8-disubstituted-9-(heterocyclyl)purines, compositions containing these derivatives and their use in cosmetic...
6,8-Disubstituted-9-(heterocyclyl)purines for use in pharmaceutical and cosmetic compositions and applications are provided. These ...
US-1,009,3674 Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases
Disclosed are nucleopeptide compounds that include a nucleobase, and an amino acid. Certain compounds further comprise a glycoside. The compounds may...
US-1,009,3673 Tetracyclic pyridone compounds as antivirals
The invention provides compounds of Formula (I) ##STR00001## as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions...
US-1,009,3672 Process for the preparation of a spiroheterocyclic pyrrolidine dione
A process for making certain spiroheterocyclic pyrrolidine dione derivatives.
US-1,009,3671 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of...
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and Ar are as described...
US-1,009,3670 Azabenzimidazole derivative having AMPK-activating activity
Disclosed is a compound which is useful as an AMPK activator. A compound represented by formula: ##STR00001## or a pharmaceutically acceptable salt thereof,...
US-1,009,3669 Derivatives and methods of treating hepatitis B infections
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of...
US-1,009,3668 Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting...
Disclosed are substituted aromatic N-heterocyclic compounds. The disclosed compounds typically exhibit kinase inhibition activity, for example, and inhibit Mnk1...
US-1,009,3667 Coumarinyl-thiazole-sulfonyl conjugate and preparation thereof
The present application relates to a compound of formula (I) ##STR00001## The present application also relates to synthesizing the compound of formula I and...
US-1,009,3666 Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams
Provided herein are deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams, pharmaceutical compositions thereof and methods...
US-1,009,3665 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein
The present disclosure relates to crystalline form of (S)--N--((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-py- ...
US-1,009,3664 Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
Disclosed herein are compounds which inhibit the kinase activity of dual leucine zipper (DLK) kinase (MAP3K12), pharmaceutical compositions, and methods of...
US-1,009,3663 Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
The present invention provides a compound of formula I: ##STR00001## a method for manufacturing the compounds of the invention, and its therapeutic uses. The...
US-1,009,3662 Azoline compounds substituted by a condensed ring system
Compounds of formula I are provided herein, as well as the use of these compounds for controlling invertebrate pests. Plant propagation material and...
US-1,009,3660 Sulfoximine substituted quinazolines for pharmaceutical compositions
This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I), wherein Ar, R.sup.1 and R.sup.2 are as defined in the...
US-1,009,3659 Compound useful to treat mycoses
This invention relates to a compound, as defined in the specification and as represented by the compound of formula (I): ##STR00001## useful in the treatment...
US-1,009,3658 Bifunctional compounds and use for reducing uric acid levels
Bifunctional compounds that increase uric acid excretion and reduce uric acid production, and monofunctional compounds that either increase uric acid excretion...
US-1,009,3657 Inhibitors of bruton's tyrosine kinase
This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein, which inhibit Btk. The compounds...
US-1,009,3656 Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented...
US-1,009,3655 Heteroaromatic compounds and their use as dopamine D1 ligands
The present invention provides, in part, compounds of Formula I: ##STR00001## and pharmaceutically acceptable salts thereof; processes for the preparation of;...
US-1,009,3654 Therapeutically active compounds and their methods of use
Provided are compounds useful for treating cancer and methods of treating cancer, comprising administering to a subject in need thereof a compound described...
US-1,009,3653 Vitamin D receptor-coregulator inhibitors
Described herein are compounds, pharmaceutical compositions and methods for inhibiting the expression of a vitamin D receptor target gene, inhibiting...
US-1,009,3652 Tetrahydrobenzimidazole derivatives as modulators of TNF activity
A series of substituted 4,5,6,7-tetrahydrobenzimidazole derivatives, being potent modulators of human TNF.alpha. activity, are accordingly of benefit in the...
US-1,009,3651 Ghrelin O-acyl transferase inhibitors
The present invention provides novel GOAT inhibitors and their salts and pharmaceutical compositions thereof.
US-1,009,3650 Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
The present invention provides compounds of Formula (I): ##STR00001## a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate...
US-1,009,3649 Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate, compositions and methods of...
Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate. Pharmaceutical compositions comprising the crystalline ...
US-1,009,3648 Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate, compositions and methods of...
Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate. Pharmaceutical compositions comprising the crystalline ...
US-1,009,3647 Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of...
Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate. Pharmaceutical compositions comprising the crystalline ...
US-1,009,3646 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting...
The present invention relates to compounds of formula I: ##STR00001## in which m, Y.sub.1, Y.sub.2, Y.sub.3, R.sub.1, R.sub.2a, R.sub.2b, R.sub.3a, R.sub.3b,...
US-1,009,3645 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-.beta.-D-arabinofuranosyl)cytosine, synthetic ...
A compound represented by a formula [1D] as shown below (wherein R.sup.1A, R.sup.1B, R.sup.2A, R.sup.2B, R.sup.3A and R.sup.3B represent a hydrogen atom, an...
US-1,009,3644 3-[(Benzo[D][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine type compounds and applications thereof
The present invention relates to 3-[(benzo[d][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine compounds of formula I or pharmaceutically acceptable salts thereof and...
US-1,009,3643 Method for synthesizing cyclic carbonates
The present invention relates to a method for synthesizing cyclocarbonates by reacting an epoxy compound and carbon dioxide at atmospheric pressure and elevated...
US-1,009,3642 Multitarget hedgehog pathway inhibitors and uses thereof
The present invention concerns compounds that selectively inhibit the activity of the Hedgehog (Hh) pathway, their preparation and uses thereof. The compounds...
US-1,009,3641 Process for making beraprost
A method is described for making single isomers of synthetic beraprost diol, a key intermediate for making 314-d isomer of beraprost. The method requires fewer...
US-1,009,3640 Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
The present invention provides for compounds that inhibit the activity of an anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The...
US-1,009,3639 Process for preparing furfural from biomass
Furfural is produced from biomass material containing pentosan, in high yields, in a production process comprising treating the biomass with a solution...
US-1,009,3638 Utilizing a multiphase reactor for the conversion of biomass to produce substituted furans
The present disclosure provides methods to produce substituted furans (e.g., halomethylfurfural, hydroxymethylfurfural, and furfural), by acid-catalyzed...
US-1,009,3637 Process for the catalysed conversion of psicose into 5-hydroxymethylfurfural or an alkyl ether thereof
Psicose is converted into 5-hydroxymethylfurfural or an alkyl ether thereof in a process for the catalyzed conversion of psicose, including the steps of: a....
US-1,009,3636 Method for synthesizing bio-plasticizers using acidic ionic liquids as catalysts
Synthesizing bio-plasticizers with acidic ionic liquids as catalysts. The acidic ionic liquids are Bronsted acidic ionic liquids, which are composed of alkyl...
US-1,009,3635 MAGL inhibitors
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as...
US-1,009,3634 Process for the preparation of substituted phenoxyphenyl ketones
The present invention relates to a process for the preparation of the ketone compounds (IA) ##STR00001## and their use as intermediates for the preparation of...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.